Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06612476
NA

Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients

Sponsor: Ningbo No. 1 Hospital

View on ClinicalTrials.gov

Summary

In this multicenter, prospective, randomized controlled study, we aimed to figure out, compared with the global chronic obstructive pulmonary disease initiative (GOLD) guideline -guided antibiotic therapy, whether Interleukin 6 (IL6)-guided antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) can lead to a reduction in the use of antibiotics without increasing the rate of treatment failure.

Official title: Interleukin 6-guided Antibiotic Prescriptions in AECOPD Inpatients: a Multicenter Randomized Controlled Trial

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

440

Start Date

2024-09-20

Completion Date

2026-08-31

Last Updated

2024-09-25

Healthy Volunteers

No

Interventions

DRUG

Interleukin 6-guided antibiotic therapy

In Interleukin-6 group, antibiotic prescription decisions will made according to the results of IL-6.

DRUG

GOLD-guided antibiotic therapy

In guideline group, antibiotic prescription decisions will made according to the recommendations of GOLD guideline.